dc.contributor.author | Ramaekers, BLT | en_US |
dc.contributor.author | Riemsma, R | en_US |
dc.contributor.author | Tomini, F | en_US |
dc.contributor.author | van Asselt, T | en_US |
dc.contributor.author | Deshpande, S | en_US |
dc.contributor.author | Duffy, S | en_US |
dc.contributor.author | Armstrong, N | en_US |
dc.contributor.author | Severens, JL | en_US |
dc.contributor.author | Kleijnen, J | en_US |
dc.contributor.author | Joore, MA | en_US |
dc.date.accessioned | 2019-03-12T17:09:51Z | |
dc.date.issued | 2017-02 | en_US |
dc.identifier.issn | 1170-7690 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/56125 | |
dc.description.sponsorship | This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme (see the HTA programme website for further project information [http://www.hta.ac.uk]). | en_US |
dc.format.extent | 191 - 202 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | PHARMACOECONOMICS | en_US |
dc.rights | Creative Commons Attribution | |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.title | Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal | en_US |
dc.type | Article | |
dc.rights.holder | The Author(s) 2016 | |
dc.identifier.doi | 10.1007/s40273-016-0445-5 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000393114500005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 2 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 35 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |